chr12-53328272-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001173467.3(SP7):c.1170G>T(p.Glu390Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000323 in 1,610,996 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001173467.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SP7 | NM_001173467.3 | c.1170G>T | p.Glu390Asp | missense_variant | 3/3 | ENST00000536324.4 | |
SP7 | NM_152860.2 | c.1170G>T | p.Glu390Asp | missense_variant | 2/2 | ||
SP7 | NM_001300837.2 | c.1116G>T | p.Glu372Asp | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SP7 | ENST00000536324.4 | c.1170G>T | p.Glu390Asp | missense_variant | 3/3 | 2 | NM_001173467.3 | P1 | |
SP7 | ENST00000303846.3 | c.1170G>T | p.Glu390Asp | missense_variant | 2/2 | 1 | P1 | ||
SP7 | ENST00000537210.2 | c.1116G>T | p.Glu372Asp | missense_variant | 2/2 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000287 AC: 7AN: 243924Hom.: 0 AF XY: 0.0000226 AC XY: 3AN XY: 132522
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1458852Hom.: 0 Cov.: 29 AF XY: 0.0000221 AC XY: 16AN XY: 725580
GnomAD4 genome AF: 0.000158 AC: 24AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74310
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2022 | The c.1170G>T (p.E390D) alteration is located in exon 3 (coding exon 2) of the SP7 gene. This alteration results from a G to T substitution at nucleotide position 1170, causing the glutamic acid (E) at amino acid position 390 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 15, 2022 | This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 390 of the SP7 protein (p.Glu390Asp). This variant is present in population databases (rs373328657, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with SP7-related conditions. ClinVar contains an entry for this variant (Variation ID: 1385531). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The aspartic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at